Nasdaq

Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab

ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...
FierceBiotech

Abbott's Panbio antigen test obtains new European approvals for mass COVID-19 screening

Abbott has received new COVID-19 diagnostic approvals in Europe for its rapid Panbio antigen test, clearing it for self-performed screening under supervision as well as widespread use by people who ...
Nasdaq

Abbott Receives CE Mark For Two New Uses Of Panbio COVID-19 Ag Rapid Test Device

(RTTNews) - Abbott (ABT) said it has received CE Mark for two new uses of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus: asymptomatic testing and self-swabbing.
Business Insider

Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge

- Philippines scales its testing capability with two Abbott tests – a quick, patient-friendly rapid antigen test and lab-based quantitative antibody test - The Abbott Panbio™ COVID-19 Antigen Rapid ...
FierceBiotech

Abbott's rapid antigen COVID-19 test cleared in Europe for at-home, direct-to-consumer sales

Even as Abbott continues to anticipate a steep drop-off in its COVID-19 testing sales boom—and recently updated its financial projections for the year to reflect that—testing demand has yet to ...
Reuters

Canada signs deal with Abbott for Panbio COVID-19 Antigen tests

OTTAWA, Oct 6 (Reuters) - Canada said on Tuesday that it had signed a deal with Abbott Rapid Diagnostics to purchase up to 20.5 million Panbio COVID-19 Antigen rapid tests. Health Canada has also ...